S&Co Inc Vertex Pharmaceuticals Inc Transaction History
S&Co Inc
- $1.49 Billion
- Q1 2025
A detailed history of S&Co Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, S&Co Inc holds 4,103 shares of VRTX stock, worth $1.83 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
4,103Holding current value
$1.83 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,831Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.49 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.47 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.25 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...